Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Respiratory Tract Diseases
>>
AbbVie
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
veliparib
(ABT-888) / AbbVie
ABT-751
/ AbbVie, Eisai
Botox
(onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
linifanib
(ABT-869) / AbbVie
lorvotuzumab mertansine
(IMGN901) / AbbVie
navitoclax
(ABT 263) / AbbVie
thrombospondin-1 mimetic
(ABT-510) / AbbVie
volociximab
(M200) / AbbVie, Biogen
